CRISPR-BASED MOLECULAR DETECTION METHODS FOR RNA VIRUSES: APPLICATIONS IN THE DIAGNOSIS AND TREATMENT OF COVID-19 VARIANTS
Authors:
- Myle Akshay KiranMKMyle Akshay Kiran
- Muhammed A. BakhrebahMBMuhammed A. Bakhrebah
- Muhammad A. HalwaniMHMuhammad A. Halwani
- Bashayer M. AlShehailBABashayer M. AlShehail
- Abdulrazzag Abdulaziz OthmanAOAbdulrazzag Abdulaziz Othman
- Abdullah Jaber AlShahraniAAAbdullah Jaber AlShahrani
- Fahd A. AlshehriFAFahd A. Alshehri
- Ahmad A. AlshehriAAAhmad A. Alshehri
- Mohammed AlissaMohammed Alissa
- Ali A. RabaanARAli A. Rabaan
Open Access
- 31 July 2023
- journal article
- research article
- Published by Green Publication
- Vol. 30 (16) , 477-490
Abstract
Introduction: The COVID-19 pandemic caused by the SARS-CoV-2 virus has affected millions worldwide. In this study, we investigate the potential of CRISPR systems Cas12 and Cas13 for diagnosing and treating RNA viruses, particularly SARS-CoV-2. Aim: This study aims to explore the role and application of CRISPR-system-based methods in detecting and treating RNA viruses, especially SARS-CoV-2, using Cas12 and Cas13 proteins. Materials and Methodology: CRISPR enzymes, types V and VI, can target RNA or DNA through processes known as RNA and DNA targeting. Cas12 and Cas13 enzymes are specific for single-stranded RNA viruses and play a crucial role in diagnosing and treating these viruses. We used the DETECTR assay to detect mutations in SARS-CoV-2, including circulating and rare or new variants, in 304 respiratory swab samples collected from patients.Keywords
This publication has 54 references indexed in Scilit:
- Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS‐CoV‐2 and Other Respiratory VirusesSmall, 2021
- CRISPR/Cas technology as a promising weapon to combat viral infectionsBioEssays, 2021
- Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosisBiosensors and Bioelectronics, 2020
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic targetIntensive Care Medicine, 2020
- Emerging coronaviruses: Genome structure, replication, and pathogenesisJournal of Medical Virology, 2020
- CRISPR-Based Technologies for the Manipulation of Eukaryotic GenomesCell, 2017
- CRISPR/Cas9-mediated gene editing in human tripronuclear zygotesProtein & Cell, 2015
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013